Insufficient scRNA-seq data for expression of FERD3L at single-cell level.
Insufficient scRNA-seq data for expression of FERD3L at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 20% | 0.30 | 363 / 1809 | 0% | 0 | 0 / 472 |
breast | 17% | 0.23 | 80 / 459 | 0% | 0 | 0 / 1118 |
bladder | 14% | 0.14 | 3 / 21 | 0% | 0 | 0 / 504 |
heart | 11% | 0.13 | 93 / 861 | 0% | 0 | 0 / 0 |
brain | 9% | 0.14 | 239 / 2642 | 0% | 0.02 | 2 / 705 |
adipose | 6% | 0.08 | 78 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 6% | 0.08 | 84 / 1335 | 0% | 0 | 0 / 0 |
thymus | 6% | 0.07 | 40 / 653 | 0% | 0 | 0 / 605 |
esophagus | 4% | 0.05 | 56 / 1445 | 0% | 0 | 0 / 183 |
adrenal gland | 1% | 0.01 | 2 / 258 | 2% | 0.03 | 4 / 230 |
spleen | 2% | 0.02 | 5 / 241 | 0% | 0 | 0 / 0 |
uterus | 2% | 0.02 | 3 / 170 | 0% | 0 | 0 / 459 |
stomach | 2% | 0.02 | 6 / 359 | 0% | 0 | 0 / 286 |
muscle | 2% | 0.02 | 13 / 803 | 0% | 0 | 0 / 0 |
intestine | 2% | 0.02 | 15 / 966 | 0% | 0 | 0 / 527 |
liver | 1% | 0.01 | 3 / 226 | 0% | 0 | 0 / 406 |
pancreas | 0% | 0.00 | 1 / 328 | 1% | 0.02 | 1 / 178 |
lung | 1% | 0.01 | 4 / 578 | 0% | 0.00 | 1 / 1155 |
prostate | 0% | 0.00 | 1 / 245 | 0% | 0 | 0 / 502 |
peripheral blood | 0% | 0.00 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1904338 | Biological process | regulation of dopaminergic neuron differentiation |
GO_0050767 | Biological process | regulation of neurogenesis |
GO_0033504 | Biological process | floor plate development |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0048468 | Biological process | cell development |
GO_0032502 | Biological process | developmental process |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
Gene name | FERD3L |
Protein name | Fer3-like protein (Basic helix-loop-helix protein N-twist) (Class A basic helix-loop-helix protein 31) (bHLHa31) (Nephew of atonal 3) (Neuronal twist) |
Synonyms | NATO3 NTWIST BHLHA31 |
Description | FUNCTION: Transcription factor that binds to the E-box and functions as inhibitor of transcription. DNA binding requires dimerization with an E protein. Inhibits transcription activation by ASCL1/MASH1 by sequestering E proteins (By similarity). . |
Accessions | ENST00000275461.3 Q96RJ6 |